Bayaca, Artemio D.

HRN: 21-28-23  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/04/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/04/2022
05/11/2022
IV
4.5g
Q6
Septic Shock Sec To HAP?
Waiting Final Action 

Indication:  Empiric    Type of Infection:  PneumoniaBloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: